QIAGEN Gaithersburg, Inc
Study for performance evaluation of the QIAstat-Dx® BCID Plus AMR GPF-Panel and the QIAstat Dx® BCID Plus AMR GN-Panel in comparison with other chosen comparator methods
Blood Disease
QIAstat-Dx® BCID GN and GPF Plus AMR Panels
This multicenter study aims to evaluate the performance of QIAstat-Dx® BCID Plus AMR GPF-Panel and the QIAstat Dx® BCID Plus AMR GN-Panel with another validated comparator method.
Study Type : | OBSERVATIONAL |
Estimated Enrollment : | 2880 participants |
Official Title : | Clinical Performance Evaluation Study of the QIAstat-Dx® BCID GN and GPF Plus AMR Panels on Positive Blood Culture and Pure Colony Isolates From Subjects With Signs and Symptoms of Bloodstream Infection |
Actual Study Start Date : | 2023-12-01 |
Estimated Primary Completion Date : | 2025-01 |
Estimated Study Completion Date : | 2025-03 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
QIAGEN
Manchester, United Kingdom,